University Medical Center Hamburg

Hamburg 20246

1 studies enrolling now · 2 studies all time

What they study most

Intracerebral Hemorrhage, Ischemic Attack, Transient

Studies at this site

• Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 — Recruiting now
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial — Stopped early